IntrinsicIntrinsic
← Scroll for more →

Financial Statements — PRTO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents17.0814.7449.6612.5531.5091.46162.8051.7689.5852.2339.5933.7733.9821.0424.1347.5033.8225.4435.7240.74
Short-term Investments125.42121.05105.90120.1290.7232.907.4929.74--2.9925.9940.2746.3865.5860.2448.8264.6462.1655.5153.02
Total Current Assets146.15140.00159.50135.64125.09126.53172.1685.0892.2157.9168.7177.8184.2794.6286.1598.67101.0990.6993.1195.70
Property, Plant & Equipment1.320.670.760.830.910.991.031.111.191.211.301.401.441.521.591.661.641.681.721.73
Goodwill----------------------------29.5029.5229.5229.5229.5229.52
Total Non-current Assets*29.9451.9349.968.9931.8442.039.309.019.4310.2210.2510.6510.8811.7927.1449.9253.7970.5779.4885.00
Total Assets176.09191.92209.47144.64156.93168.56181.4594.09101.6568.1378.9588.4795.14106.41113.29148.59154.88161.26172.60180.70
Accounts Payable4.664.033.474.505.302.314.432.301.390.972.432.501.854.081.590.460.390.540.950.93
Short-term Debt------------------------------------0.00--
Total Current Liabilities13.328.9210.949.919.767.0210.968.645.655.506.156.784.936.415.743.713.492.864.303.69
Total Non-current Liabilities*1.461.792.122.442.753.063.363.663.954.234.484.744.985.235.475.705.936.166.386.60
Total Liabilities14.7810.7213.0612.3512.5110.0714.3212.309.609.7310.6311.519.9211.6411.219.419.439.0210.6810.29
Retained Earnings(341.87)(320.20)(302.42)(285.11)(271.85)(256.89)(244.98)(232.21)(220.99)(211.48)(200.38)(190.16)(180.30)(169.01)(159.96)(121.00)(113.31)(104.77)(94.01)(83.78)
Total Stockholder Equity161.31181.21196.41132.29144.42158.48167.1381.7992.0558.4168.3276.9685.2394.77102.08139.18145.46152.24161.91170.41
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Research & Development16.9513.5613.129.5910.779.159.508.076.397.756.386.227.255.144.993.473.085.274.074.09
Selling, General & Admin6.376.075.965.175.824.984.814.264.274.104.664.484.894.595.004.515.625.616.226.74
Total Operating Expenses23.3219.6319.0814.7616.5914.1214.3112.3310.6611.8511.0410.7012.149.7339.517.978.7110.8710.2910.83
Operating Income(23.32)(19.63)(19.08)(14.76)(16.59)(14.12)(14.31)(12.33)(10.66)(11.85)(11.04)(10.70)(12.14)(9.73)(39.51)(7.97)(8.70)(10.87)(10.29)(10.83)
Net Income(21.67)(17.78)(17.31)(13.26)(14.96)(11.91)(12.77)(11.22)(9.51)(11.09)(10.22)(9.86)(11.29)(9.04)(38.97)(7.69)(8.54)(10.75)(10.23)(10.78)
Basic EPS(0.36)(0.31)(0.39)(0.31)(0.35)(0.29)(0.25)(0.50)(0.45)(0.97)(0.90)(0.87)(1.00)(0.80)(3.42)(0.68)(0.80)(0.96)----
Diluted EPS(0.36)(0.31)(0.39)(0.31)(0.35)(0.29)(0.25)(0.50)(0.45)(0.97)(0.90)(0.87)(1.00)(0.80)(3.46)(0.68)(0.80)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(15.39)(21.34)(16.95)(12.45)(12.25)(14.71)(9.31)(8.43)(7.69)(10.38)(8.70)(6.56)(9.41)(12.89)(5.03)(5.35)(5.12)(10.96)(6.91)(6.20)
Capital Expenditures0.33--0.020.000.020.040.000.010.06--0.000.040.000.010.010.080.020.010.04(0.06)
Free Cash Flow*(15.72)--(16.97)(12.46)(12.27)(14.76)(9.31)(8.44)(7.74)--(8.70)(6.60)(9.41)(12.89)(5.03)(5.43)(5.14)(10.97)(6.95)(6.14)
Investing Cash Flow17.75(14.72)(26.91)(6.51)(47.72)(58.35)22.50(29.39)2.9523.1014.526.3822.359.86(18.34)19.0513.500.751.890.11
Financing Cash Flow(0.03)1.1480.960.010.011.7397.850.0042.09(0.08)0.00(0.03)0.00(0.06)0.00(0.02)0.00(0.07)0.000.00
← Scroll for more columns →

* Derived from reported values